+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ineffective Esophageal Motility Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 302 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5915981
Description Jump to:
global market for ineffective esophageal motility treatment is poised for substantial growth, with projections indicating a robust CAGR of 7.0% over the forecast period, reaching a valuation of approximately US$ 7.21 Billion by 2031. This growth is fueled by several factors, prominently the escalating prevalence of gastroesophageal reflux disease (GERD), hiatal hernia, and dysphagia worldwide.

Obesity, recognized as a leading cause of GERD, has become a global health concern, contributing significantly to the rise in esophageal motility issues. Studies indicate that 15% to 25% of individuals worldwide suffer from GERD, with prevalence higher in Western countries such as the United States. The aging population further compounds the demand for treatments, as age-related declines in esophageal function and saliva production exacerbate symptoms of dysphagia and GERD.

Moreover, the emergence of hiatal hernia significantly influences the progression of acid reflux into chronic conditions, driving the need for effective treatment options. In emerging economies like South Africa, Brazil, China, Mexico, and India, where many patients remain underserved, there exists a substantial market opportunity for medical device companies to address the growing healthcare needs.

However, challenges persist, including the adverse effects and high costs associated with surgical treatments. Anti-reflux fundoplication procedures often lead to obstructive mechanical side effects, complicating patient outcomes and necessitating further interventions. Additionally, the high price of medical equipment such as gastroscopes and esophagoscopes poses a barrier to market growth, alongside concerns regarding infection risks associated with contaminated endoscopes.

Country-wise Insights:

United States

The United States dominates the global market, accounting for approximately 43.4% of the market share in 2023. The prevalence of obesity in the U.S., coupled with increased incidences of esophageal injuries, propels market growth.

China

China, with a market share of around 7.3% in 2023, showcases a growing prevalence of dysphagia, especially among the elderly population, driving demand for esophageal motility treatments.

Germany

Germany, holding a market share of about 5.9% in 2023, is witnessing a rise in esophageal disorders attributed to increased consumption of beverages like alcohol and coffee, necessitating effective treatment options.

Competition Landscape: Key Players

Key players in the ineffective esophageal motility treatment market, including Johnson & Johnson, Medtronic Plc, AstraZeneca Plc, GlaxoSmithKline Plc, and others, are actively engaged in expanding their offerings through clinical trials, product launches, and strategic distribution channel enhancements to cater to the evolving needs of consumers worldwide.

Key Companies Covered in the market include:

  • Johnson & Johnson
  • Mylan Pharmaceutical
  • MediGus Ltd
  • Torax Medical
  • Medtronic Plc
  • AstraZeneca Plc
  • Teva Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical Company Limited
  • Glaxosmithkline Plc.
  • Bayer Ag
  • Pfixer Inc
  • Bausch Health Companies Inc.
  • Laborie
  • Mederi Therapeutics, Inc.
  • Becton, Dickinson and Company.
  • EndoGastic Solution Inc
  • Olympus
  • Pentax

Key Segments Covered in Ineffective Esophageal Motility Treatment Industry Research

Product:

  • Devices
  • Reflux Management Systems
  • Endoscopic Pain Modulators
  • Endostaplers
  • Radiofrequency (RF) Ablation Devices
  • Myotomy
  • Drugs
  • H2 Receptor Antagonist
  • Antacids
  • Proton Pump Inhibitors
  • Dopamine Antagonist
  • Prokinetic Agents
  • Calcium Channel Blockers

Indications:

  • Dysphagia
  • GERD
  • Burning chest pain
  • Achalasia

End User:

  • Institutional sales
  • Hospitals
  • Ambulatory Surgical Centers
  • Retail Sales
  • Retail Pharmacies
  • Drug Stores
  • Mail order Pharmacies

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Ineffective Esophageal Motility Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Ineffective Esophageal Motility Treatment Market Outlook, 2018 - 2031
3.1. Global Ineffective Esophageal Motility Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Devices
3.1.1.1.1. Reflux Management Systems
3.1.1.1.2. Endoscopic Pain Modulators
3.1.1.1.3. Endostaplers
3.1.1.1.4. Radiofrequency (RF) Ablation Devices
3.1.1.1.5. Myotomy
3.1.1.2. Drugs
3.1.1.2.1. H2 Receptor Antagonist
3.1.1.2.2. Antacids
3.1.1.2.3. Proton Pump Inhibitors
3.1.1.2.4. Dopamine Antagonist
3.1.1.2.5. Prokinetic Agents
3.1.1.2.6. Calcium Channel Blockers
3.2. Global Ineffective Esophageal Motility Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Dysphagia
3.2.1.2. GERD
3.2.1.3. Burning chest pain
3.2.1.4. Achalasia
3.3. Global Ineffective Esophageal Motility Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Institutional sales
3.3.1.1.1. Hospitals
3.3.1.1.2. Ambulatory Surgical Centers
3.3.1.2. Retail Sales
3.3.1.2.1. Retail Pharmacies
3.3.1.2.2. Drug Stores
3.3.1.2.3. Mail order Pharmacies
3.4. Global Ineffective Esophageal Motility Treatment Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Ineffective Esophageal Motility Treatment Market Outlook, 2018 - 2031
4.1. North America Ineffective Esophageal Motility Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Devices
4.1.1.1.1. Reflux Management Systems
4.1.1.1.2. Endoscopic Pain Modulators
4.1.1.1.3. Endostaplers
4.1.1.1.4. Radiofrequency (RF) Ablation Devices
4.1.1.1.5. Myotomy
4.1.1.2. Drugs
4.1.1.2.1. H2 Receptor Antagonist
4.1.1.2.2. Antacids
4.1.1.2.3. Proton Pump Inhibitors
4.1.1.2.4. Dopamine Antagonist
4.1.1.2.5. Prokinetic Agents
4.1.1.2.6. Calcium Channel Blockers
4.2. North America Ineffective Esophageal Motility Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Dysphagia
4.2.1.2. GERD
4.2.1.3. Burning chest pain
4.2.1.4. Achalasia
4.3. North America Ineffective Esophageal Motility Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Institutional sales
4.3.1.1.1. Hospitals
4.3.1.1.2. Ambulatory Surgical Centers
4.3.1.2. Retail Sales
4.3.1.2.1. Retail Pharmacies
4.3.1.2.2. Drug Stores
4.3.1.2.3. Mail order Pharmacies
4.4. North America Ineffective Esophageal Motility Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
4.4.1.2. U.S. Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
4.4.1.3. U.S. Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
4.4.1.4. Canada Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
4.4.1.5. Canada Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
4.4.1.6. Canada Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Ineffective Esophageal Motility Treatment Market Outlook, 2018 - 2031
5.1. Europe Ineffective Esophageal Motility Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Devices
5.1.1.1.1. Reflux Management Systems
5.1.1.1.2. Endoscopic Pain Modulators
5.1.1.1.3. Endostaplers
5.1.1.1.4. Radiofrequency (RF) Ablation Devices
5.1.1.1.5. Myotomy
5.1.1.2. Drugs
5.1.1.2.1. H2 Receptor Antagonist
5.1.1.2.2. Antacids
5.1.1.2.3. Proton Pump Inhibitors
5.1.1.2.4. Dopamine Antagonist
5.1.1.2.5. Prokinetic Agents
5.1.1.2.6. Calcium Channel Blockers
5.2. Europe Ineffective Esophageal Motility Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Dysphagia
5.2.1.2. GERD
5.2.1.3. Burning chest pain
5.2.1.4. Achalasia
5.3. Europe Ineffective Esophageal Motility Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Institutional sales
5.3.1.1.1. Hospitals
5.3.1.1.2. Ambulatory Surgical Centers
5.3.1.2. Retail Sales
5.3.1.2.1. Retail Pharmacies
5.3.1.2.2. Drug Stores
5.3.1.2.3. Mail order Pharmacies
5.4. Europe Ineffective Esophageal Motility Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.2. Germany Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.3. Germany Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.4. U.K. Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.5. U.K. Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.6. U.K. Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.7. France Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.8. France Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.9. France Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.10. Italy Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.11. Italy Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.12. Italy Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.13. Turkey Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.14. Turkey Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.15. Turkey Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.16. Russia Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.17. Russia Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.18. Russia Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.19. Rest of Europe Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.20. Rest of Europe Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.21. Rest of Europe Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Ineffective Esophageal Motility Treatment Market Outlook, 2018 - 2031
6.1. Asia Pacific Ineffective Esophageal Motility Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Devices
6.1.1.1.1. Reflux Management Systems
6.1.1.1.2. Endoscopic Pain Modulators
6.1.1.1.3. Endostaplers
6.1.1.1.4. Radiofrequency (RF) Ablation Devices
6.1.1.1.5. Myotomy
6.1.1.2. Drugs
6.1.1.2.1. H2 Receptor Antagonist
6.1.1.2.2. Antacids
6.1.1.2.3. Proton Pump Inhibitors
6.1.1.2.4. Dopamine Antagonist
6.1.1.2.5. Prokinetic Agents
6.1.1.2.6. Calcium Channel Blockers
6.2. Asia Pacific Ineffective Esophageal Motility Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Dysphagia
6.2.1.2. GERD
6.2.1.3. Burning chest pain
6.2.1.4. Achalasia
6.3. Asia Pacific Ineffective Esophageal Motility Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Institutional sales
6.3.1.1.1. Hospitals
6.3.1.1.2. Ambulatory Surgical Centers
6.3.1.2. Retail Sales
6.3.1.2.1. Retail Pharmacies
6.3.1.2.2. Drug Stores
6.3.1.2.3. Mail order Pharmacies
6.4. Asia Pacific Ineffective Esophageal Motility Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.2. China Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.3. China Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.4. Japan Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.5. Japan Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.6. Japan Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.7. South Korea Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.8. South Korea Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.9. South Korea Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.10. India Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.11. India Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.12. India Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.13. Southeast Asia Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.14. Southeast Asia Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.15. Southeast Asia Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Ineffective Esophageal Motility Treatment Market Outlook, 2018 - 2031
7.1. Latin America Ineffective Esophageal Motility Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Devices
7.1.1.1.1. Reflux Management Systems
7.1.1.1.2. Endoscopic Pain Modulators
7.1.1.1.3. Endostaplers
7.1.1.1.4. Radiofrequency (RF) Ablation Devices
7.1.1.1.5. Myotomy
7.1.1.2. Drugs
7.1.1.2.1. H2 Receptor Antagonist
7.1.1.2.2. Antacids
7.1.1.2.3. Proton Pump Inhibitors
7.1.1.2.4. Dopamine Antagonist
7.1.1.2.5. Prokinetic Agents
7.1.1.2.6. Calcium Channel Blockers
7.2. Latin America Ineffective Esophageal Motility Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
7.2.1.1. Dysphagia
7.2.1.2. GERD
7.2.1.3. Burning chest pain
7.2.1.4. Achalasia
7.3. Latin America Ineffective Esophageal Motility Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Institutional sales
7.3.1.1.1. Hospitals
7.3.1.1.2. Ambulatory Surgical Centers
7.3.1.2. Retail Sales
7.3.1.2.1. Retail Pharmacies
7.3.1.2.2. Drug Stores
7.3.1.2.3. Mail order Pharmacies
7.4. Latin America Ineffective Esophageal Motility Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.2. Brazil Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
7.4.1.3. Brazil Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.4. Mexico Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.5. Mexico Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
7.4.1.6. Mexico Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.7. Argentina Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.8. Argentina Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
7.4.1.9. Argentina Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.10. Rest of Latin America Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.11. Rest of Latin America Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
7.4.1.12. Rest of Latin America Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Ineffective Esophageal Motility Treatment Market Outlook, 2018 - 2031
8.1. Middle East & Africa Ineffective Esophageal Motility Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Devices
8.1.1.1.1. Reflux Management Systems
8.1.1.1.2. Endoscopic Pain Modulators
8.1.1.1.3. Endostaplers
8.1.1.1.4. Radiofrequency (RF) Ablation Devices
8.1.1.1.5. Myotomy
8.1.1.2. Drugs
8.1.1.2.1. H2 Receptor Antagonist
8.1.1.2.2. Antacids
8.1.1.2.3. Proton Pump Inhibitors
8.1.1.2.4. Dopamine Antagonist
8.1.1.2.5. Prokinetic Agents
8.1.1.2.6. Calcium Channel Blockers
8.2. Middle East & Africa Ineffective Esophageal Motility Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Dysphagia
8.2.1.2. GERD
8.2.1.3. Burning chest pain
8.2.1.4. Achalasia
8.3. Middle East & Africa Ineffective Esophageal Motility Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Institutional sales
8.3.1.1.1. Hospitals
8.3.1.1.2. Ambulatory Surgical Centers
8.3.1.2. Retail Sales
8.3.1.2.1. Retail Pharmacies
8.3.1.2.2. Drug Stores
8.3.1.2.3. Mail order Pharmacies
8.4. Middle East & Africa Ineffective Esophageal Motility Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.2. GCC Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
8.4.1.3. GCC Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.4. South Africa Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.5. South Africa Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
8.4.1.6. South Africa Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.7. Egypt Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.8. Egypt Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
8.4.1.9. Egypt Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.10. Nigeria Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.11. Nigeria Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
8.4.1.12. Nigeria Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Ineffective Esophageal Motility Treatment Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Ineffective Esophageal Motility Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Ineffective Esophageal Motility Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Indication Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Johnson & Johnson
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Mylan Pharmaceutical
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. MediGus Ltd
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Dr. Reddy’s Laboratories Ltd.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Torax Medical
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Medtronic Plc
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. AstraZeneca Plc
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Teva Pharmaceutical Industries Ltd
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Glaxosmithkline Plc.
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Bayer Ag
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Pfixer Inc
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Bausch Health Companies Inc.
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Laborie
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Johnson & Johnson
  • Mylan Pharmaceutical
  • MediGus Ltd
  • Torax Medical
  • Medtronic Plc
  • AstraZeneca Plc
  • Teva Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical Company Limited
  • Glaxosmithkline Plc.
  • Bayer Ag
  • Pfixer Inc
  • Bausch Health Companies Inc.
  • Laborie
  • Mederi Therapeutics, Inc.
  • Becton, Dickinson and Company.
  • EndoGastic Solution Inc
  • Olympus
  • Pentax

Methodology

Loading
LOADING...

Related Topics

Related Reports

Esophageal Dysphagia Global Market Report 2024 - Product Image

Esophageal Dysphagia Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Dysphagia Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Dysphagia Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 178 Pages
  • Global
Global Diabetic Gastroparesis Treatment Market Report and Forecast 2023-2031 - Product Image

Global Diabetic Gastroparesis Treatment Market Report and Forecast 2023-2031

  • Report
  • 160 Pages
  • Global
From
Dysphagia Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Dysphagia Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 189 Pages
  • Global
From
Gastric Motility Disorder Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type - Product Image

Gastric Motility Disorder Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type

  • Report
  • 97 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.